指南与共识泌尿系感染

女性复发性非复杂性尿路感染:AUA/CUA/SUFU指南

Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline.
指南 / 共识 · J Urol · 2019-07-08

该指南由AUA/CUA/SUFU制定,旨在为女性复发性尿路感染(rUTI)的评估与管理提供指导,以减少抗生素不当使用及耐药风险。指南基于系统评价,证据强度分为A、B、C级,推荐强度分为强、中、条件性推荐,证据不足时提供临床原则与专家意见。

要点

  • 指南旨在指导女性rUTI的评估与管理,减少抗生素不当使用和耐药。
  • 证据强度分为A(高)、B(中)、C(低),推荐分为强、中、条件性推荐。
  • 证据不足时提供临床原则和专家意见作为补充指导。

核心结论

  • 随着对rUTI病理生理学的新认识、对重复抗菌治疗不良反应的重视、细菌耐药率上升及对急性膀胱炎和rUTI自然史与临床结局的更佳报告,rUTI的长期诊断、治疗和管理能力已有所提升。
  • 随着新数据的出现,本文件将进行审查以确保其持续准确性。

研究设计与样本

  • 由太平洋西北循证实践中心的方法学团队进行系统评价以支持本指南。
  • 研究馆员检索了Ovid MEDLINE(1946年至2018年1月第1周)、Cochrane对照试验中心注册库(截至2017年12月)和Embase(截至2018年1月16日),并于2018年9月20日进行了更新文献检索。

主要发现

  • 当证据充分时,证据体被赋予A(高)、B(中)或C(低)的证据强度评级。
  • 此类循证声明以强推荐、中等推荐或条件性推荐的形式提供。
  • 在证据不足的情况下,提供临床原则和专家意见作为补充指导。

关键数值与推荐

  • 证据强度评级:A(高)、B(中)、C(低)。
  • 推荐强度:强推荐、中等推荐、条件性推荐。
  • 证据不足时采用临床原则和专家意见。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This document seeks to establish guidance for the evaluation and management of women with recurrent urinary tract infections (rUTI) to prevent inappropriate use of antibiotics, decrease the risk of antibiotic resistance, reduce adverse effects of antibiotic use, provide guidance on antibiotic and non-antibiotic strategies for prevention, and improve clinical outcomes and quality of life by reducing recurrence of urinary tract infection (UTI) events. MATERIALS AND METHODS: The systematic review utilized to inform this guideline was conducted by a methodology team at the Pacific Northwest Evidence-based Practice Center. A research librarian conducted searches in Ovid MEDLINE (1946 to January Week 1 2018), Cochrane Central Register of Controlled Trials (through December 2017) and Embase (through January 16, 2018). An update literature search was conducted on September 20, 2018. RESULTS: When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low). Such evidence-based statements are provided as Strong, Moderate, or Conditional Recommendations. In instances of insufficient evidence, additional guidance is provided as Clinical Principles and Expert Opinions. CONCLUSIONS: Our ability to diagnose, treat, and manage rUTI long-term has evolved due to additional insights into the pathophysiology of rUTI, a new appreciation for the adverse effects of repetitive antimicrobial therapy, rising rates of bacterial antimicrobial resistance (AMR), and better reporting of the natural history and clinical outcomes of acute cystitis and rUTI. As new data continue to emerge in this space, this document will undergo review to ensure continued accuracy.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Anger J, Lee U, Ackerman AL, et al. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. J Urol. 2019. PMID: 31042112. doi:10.1097/JU.0000000000000296

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。